Thrivent Financial for Lutherans’s Vor Biopharma VOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-149,690
| Closed | -$317K | – | 2550 |
|
|
2023
Q3 | $317K | Sell |
149,690
-162,962
| -52% | -$345K | ﹤0.01% | 2296 |
|
|
2023
Q2 | $967K | Sell |
312,652
-2,557
| -0.8% | -$7.91K | ﹤0.01% | 1826 |
|
|
2023
Q1 | $1.7M | Buy |
315,209
+8,398
| +3% | +$45.2K | ﹤0.01% | 1408 |
|
|
2022
Q4 | $2.04M | Buy |
306,811
+4,399
| +1% | +$29.2K | 0.01% | 1246 |
|
|
2022
Q3 | $1.2M | Buy |
302,412
+15,560
| +5% | +$61.9K | ﹤0.01% | 1556 |
|
|
2022
Q2 | $1.43M | Sell |
286,852
-18,973
| -6% | -$94.3K | ﹤0.01% | 1462 |
|
|
2022
Q1 | $1.85M | Sell |
305,825
-318
| -0.1% | -$1.92K | ﹤0.01% | 1382 |
|
|
2021
Q4 | $3.56M | Buy |
306,143
+2,345
| +0.8% | +$27.3K | 0.01% | 1045 |
|
|
2021
Q3 | $4.76M | Buy |
303,798
+25,318
| +9% | +$397K | 0.01% | 909 |
|
|
2021
Q2 | $5.19M | Buy |
278,480
+703
| +0.3% | +$13.1K | 0.01% | 906 |
|
|
2021
Q1 | $12M | Buy |
+277,777
| New | +$12M | 0.03% | 606 |
|